Coherus BioSciences Inc (NASDAQ:CHRS)
| 15.12 Delayed Data As of May 14 |  +1.21 / +8.70%Today’s Change | 13.53 Today|||52-Week Range 22.22 | -13.00% Year-to-Date |
Latest CHRS News | Press Releases
| Coherus BioSciences Inc (CHRS) Q1 2021 Earnings Call Transcript May 06 / MotleyFool.com - Paid Partner Content | Coherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates May 06 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 13.91 |
| Today’s open | 13.87 |
| Day’s range | 13.85 - 15.20 |
| Volume | 57,146 |
| Average volume (3 months) | 1,222,216 |
| Market cap | $1.1B |
Data as of 3:59pm ET, 05/14/2021
Growth & Valuation
| Earnings growth (last year) | +43.64% |
| Earnings growth (this year) | -184.83% |
| Earnings growth (next 5 years) | +4.17% |
| Revenue growth (last year) | +33.63% |
| P/E ratio | NM |
| Price/Sales | 3.05 |
| Price/Book | 3.70 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRTXCortexyme Inc | +2.16 | +6.26% |
| RYTMRhythm Pharmaceutica... | +1.39 | +6.57% |
| SRRKScholar Rock Holding... | -0.62 | -2.17% |
| MRSNMersana Therapeutics... | +0.26 | +1.81% |
Data as of 3:59pm ET, 05/14/2021
Financials
| Next reporting date | August 11, 2021 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $475.8M |
| Annual profit (last year) | $132.2M |
| Net profit margin | 27.79% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Redwood City, California |
Forecasts
